MARC record from Internet Archive

LEADER: 02829cam a22004214a 4500
001 2007029727
003 DLC
005 20090827104547.0
008 070718s2008 nyu b 001 0 eng
010 $a 2007029727
016 7 $a101312142$2DNLM
020 $a9780826129345 (alk. paper)
020 $a082612934X (alk. paper)
035 $a(OCoLC)ocn156863742
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dYDXCP$dC#P$dHNW$dDLC
042 $apcc
043 $an-us---
050 00 $aRC483$b.B726 2008
082 00 $a616.89/122$222
100 1 $aBreggin, Peter Roger,$d1936-
245 10 $aBrain-disabling treatments in psychiatry :$bdrugs, electroshock, and the psychopharmaceutical complex /$cPeter R. Breggin.
250 $a2nd ed.
260 $aNew York :$bSpringer Pub.,$cc2008.
300 $axxx, 546 p. ;$c24 cm.
504 $aIncludes bibliographical references (p. 463-526) and index.
505 0 $aThe brain-disabling, spellbinding effects of psychiatric drugs -- Deactivation syndrome (chemical lobotomy) caused by neuroleptics -- neuroleptic-induced anguish, including agitation, despair, and depression -- Severe and potentially irreversible neurological syndromes (tardive dyskinesia and neuroleptic malignant syndrome) caused by neuroleptics -- Neuroleptic-induced neurotoxicity, brain damage, persistent cognitive deficits, dementia, and psychosis -- Recent developments in antidepressant label changes -- Antidepressant-induced mental, behavioral, and cerebral abnormalities -- Lithium and other drugs for bipolar disorder -- Electroconvulsive therapy (ECT) for depression -- From attention-deficit/hyperactivity disorder (ADHD) to bipolar disorder : diagnosing America's children -- Stimulant-induced brain damage, brain dysfunction, and psychiatric adverse reactions -- Antianxiety drugs, including behavioral abnormalities caused by Xanax and Halcion -- The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH) : drug company advocates -- Drug company deceptions -- How to more safely stop taking psychiatric drugs -- Failed promises, last resorts, and psychotherapy.
650 0 $aPsychotropic drugs$xSide effects.
650 0 $aBrain$xEffect of drugs on.
650 0 $aElectroconvulsive therapy$xComplications.
650 0 $aIatrogenic diseases.
610 10 $aUnited States.$bFood and Drug Administration.
610 12 $aUnited States.$bFood and Drug Administration.
650 12 $aMental Disorders$xtherapy$zUnited States.
650 22 $aBrain Damage, Chronic$xetiology$zUnited States.
650 22 $aDrug Industry$zUnited States.
650 22 $aElectroconvulsive Therapy$xadverse effects$zUnited States.
650 22 $aPsychotropic Drugs$xadverse effects$zUnited States.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0723/2007029727.html